NASDAQ / LIVE COMPANY INTELLIGENCE

Century Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERIPSC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / IPSC COVERAGE

What’s moving Century Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Century Therapeutics, Inc.: New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

Century Therapeutics, Inc.: New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

The story matters when it changes Century Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates

Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates

Investors are testing whether Century Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest IPSC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-12 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-16 · Period 2026-06-15SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-06-08 · Period 2026-06-08SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-27 · Period 2026-06-11SEC ↗4Official SEC filingFiled 2026-06-15 · Period 2026-06-12SEC ↗
EARNINGS / QUARTERLY TRACKER

Century Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.